These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas. Gupta S; Erickson LA Surg Pathol Clin; 2023 Mar; 16(1):119-129. PubMed ID: 36739159 [TBL] [Abstract][Full Text] [Related]
7. Late diagnosis of an index case of SDH-related paraganglioma/pheochromocytoma syndrome. Sánchez-Pacheco Tardón M; Serrano Corredor S; Carrión A; Mauri M; Yuste A Endocrinol Nutr; 2012 Feb; 59(2):148-50. PubMed ID: 22138625 [No Abstract] [Full Text] [Related]
8. Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation. Makis W; McCann K; McEwan AJ; Sawyer MB Clin Nucl Med; 2016 Mar; 41(3):204-6. PubMed ID: 26359568 [TBL] [Abstract][Full Text] [Related]
13. Novel germline SDHD mutation in a patient with recurrent familial carotid body tumor and concomitant pheochromocytoma. Kim ES; Kim SY; Mo EY; Jang DK; Moon SD; Han JH Head Neck; 2014 Dec; 36(12):E131-5. PubMed ID: 24599702 [TBL] [Abstract][Full Text] [Related]
15. Pheochromocytoma: implications in tumorigenesis and the actual management. Shah U; Giubellino A; Pacak K Minerva Endocrinol; 2012 Jun; 37(2):141-56. PubMed ID: 22691888 [TBL] [Abstract][Full Text] [Related]